Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Long-Term Investments (2022)

Updated

Vitaspring Biomedical (VSBC) recorded Long-Term Investments of $283,730 in fiscal Q3 2023 (quarter ended Oct 31, 2022), unchanged from the prior quarter.

Analysis

Vitaspring Biomedical (VSBC) Long-Term Investments (2022) Analysis & Trends

At the end of FY2022 (ended Jan 31, 2022), Vitaspring Biomedical reported Long-Term Investments of $282,469.

  • Quarterly Long-Term Investments has ranged from $282,469 in fiscal Q4 2022 to $419,554 in fiscal Q1 2023 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at $283,729 (Q2 2023), $419,554 (Q1 2023) and $282,469 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2022 283,730.00
Jul 31, 2022 283,729.00
Apr 30, 2022 419,554.00
Jan 31, 2022 282,469.00
API Access

Vitaspring Biomedical Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=VSBC&period=max&api_key=YOUR_API_KEY